Advertisement
Healthcare reform helps Catholic systems advance mission

Healthcare reform helps Catholic systems advance mission

By Sister Carol Keehan  |  April 25, 2015

Fewer than five years ago, the American healthcare system was in acute distress. Nearly 50 million people were uninsured and anyone could be denied coverage because they had a pre-existing condition.

Practice Makes Perfect: Improve outcomes by engaging patients using AIDET

Practice Makes Perfect: Improve outcomes by engaging patients using AIDET

By Robert Neuman  |  April 17, 2015

In June 2014, the Medical Group Management Association released the results of a questionnaire that ranked members' most pressing practice management challenges. In this edition of “Practice Makes Perfect,” we'll tackle No. 12 on that list: Engaging patients to improve outcomes.

U.S. healthcare—growth engine or economic drag?

U.S. healthcare—growth engine or economic drag?

By David Johnson  |  April 13, 2015

Excessive health spending creates economic activity, but diminishes national productivity. National wealth increases when efficient labor and capital investment create higher-quality products and services at lower prices.

Identifying health IT as a strategic asset

Identifying health IT as a strategic asset

By By H. Stephen Lieber  |  April 11, 2015

The value of health information technology covers much more than those five words might imply. All of us, as members of the healthcare community, strive to find and use the most effective tools and methods to improve patient care.

Community clinics use innovation to address key challenges

Community clinics use innovation to address key challenges

By Carmela Castellano-Garcia  |  April 10, 2015

The old proverb states, “Necessity is the mother of invention.” Nowhere does that ring more true than in our nation's healthcare system following the implementation of the Affordable Care Act, and it is particularly true for community clinics and health centers.

FDA ushers in the biosimilar era; now let's get the names right

FDA ushers in the biosimilar era; now let's get the names right

By Dr. Bert Petersen  |  April 06, 2015

Last month, the Food and Drug Administration approved the first biosimilar in the U.S.—Sandoz's Zarxio, a biosimilar version of Amgen's Neupogen (filgrastim). This effectively launches a new industry—one where lower-cost biosimilars will eventually create a competitive market.

High cost of cancer drugs goes beyond the price

High cost of cancer drugs goes beyond the price

By Dr. Hagop Kantarjian  |  April 04, 2015

High prices for cancer drugs are harmful to patients. During the past 15 years, the average price of cancer drugs has increased five- to 10-fold to more than $120,000 as of 2014.

Preventing readmissions requires engaging care team, employing technology

Preventing readmissions requires engaging care team, employing technology

By Ruby Raley  |  March 30, 2015

When patients are discharged, they essentially become their own care coordinator—administering medication and scheduling follow-up visits. Providers can significantly improve patient engagement and outcomes by taking advantage of outside care partnerships to help coordinate care across...

Two ways to make ACOs work better

By Dr. Elliott Fisher, Judd Gregg and Dr. James Weinstein  |  March 28, 2015

New payment models adopted by Medicare and many health plans have clearly led to better care for patients. They also might be helping to slow the overall growth of healthcare spending.

Advertisement
Modern Healthcare Daily

The top stories in healthcare business every day

The Modern Healthcare Daily News App provides you with registration-free access to the top trending healthcare business news. It's the only news you need each day.